These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37413854)

  • 21. VZV meningitis following varicella vaccine.
    Fusco D; Krawitz P; LaRussa P; Steinberg S; Gershon A; Jacobs J
    J Clin Virol; 2010 Aug; 48(4):275-7. PubMed ID: 20542464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term immunogenicity and safety of hepatitis-A and varicella vaccines in HIV-exposed uninfected and HIV-unexposed South African children.
    Mutsaerts EAML; Nunes MC; Bhikha S; Ikulinda BT; Jose L; Koen A; Moultrie A; Grobbee DE; Klipstein-Grobusch K; Weinberg A; Madhi SA
    Vaccine; 2020 May; 38(22):3862-3868. PubMed ID: 32307279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long -term persistence of antibodies against varicella in fully immunized healthcare workers: an Italian retrospective cohort study.
    Bianchi FP; Tafuri S; Larocca AMV; Germinario CA; Stefanizzi P
    BMC Infect Dis; 2021 May; 21(1):475. PubMed ID: 34034659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunology of Varicella Immunization in the elderly.
    Raeder CK; Hayney MS
    Ann Pharmacother; 2000 Feb; 34(2):228-34. PubMed ID: 10676831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of live vaccinations on immunosuppressive therapy in patients with immune-mediated inflammatory diseases, solid organ transplantation or after bone-marrow transplantation - A systematic review of randomized trials, observational studies and case reports.
    Croce E; Hatz C; Jonker EF; Visser LG; Jaeger VK; Bühler S
    Vaccine; 2017 Mar; 35(9):1216-1226. PubMed ID: 28162821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Humoral and cellular response after varicella vaccination in VZV IgG seronegative kidney transplant candidates.
    Kho MM; Zuijderwijk JM; van der Eijk AA; de Kuiper R; Boer-Verschragen MJ; Weimar W; van Besouw NM
    Vaccine; 2017 Jan; 35(1):71-76. PubMed ID: 27899225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapid molecular discrimination between infection with wild-type varicella-zoster virus and varicella vaccine virus.
    Lässker U; Harder TC; Hufnagel M; Suttorp M
    Infection; 2002 Oct; 30(5):320-2. PubMed ID: 12382096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Varicella and herpes zoster vaccine development: lessons learned.
    Warren-Gash C; Forbes H; Breuer J
    Expert Rev Vaccines; 2017 Dec; 16(12):1191-1201. PubMed ID: 29047317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children.
    Namazova-Baranova L; Habib MA; Povey M; Efendieva K; Fedorova O; Fedoseenko M; Ivleva T; Kovshirina Y; Levina J; Lyamin A; Ogorodova L; Reshetko O; Romanenko V; Ryzhenkova I; Sidorenko I; Yakovlev Y; Zhestkov A; Tatochenko V; Scherbakov M; Shpeer EL; Casabona G;
    Hum Vaccin Immunother; 2022 Jan; 18(1):1959148. PubMed ID: 34435933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The participation of varicella zoster virus in relapses of multiple sclerosis.
    Sotelo J; Ordoñez G; Pineda B; Flores J
    Clin Neurol Neurosurg; 2014 Apr; 119():44-8. PubMed ID: 24635924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccines for measles, mumps, rubella, and varicella in children.
    Di Pietrantonj C; Rivetti A; Marchione P; Debalini MG; Demicheli V
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD004407. PubMed ID: 32309885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and immunogenicity of inactivated varicella-zoster virus vaccine in adults with hematologic malignancies receiving treatment with anti-CD20 monoclonal antibodies.
    Parrino J; McNeil SA; Lawrence SJ; Kimby E; Pagnoni MF; Stek JE; Zhao Y; Chan IS; Kaplan SS
    Vaccine; 2017 Mar; 35(14):1764-1769. PubMed ID: 28268074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
    Weinberg A; Pang L; Johnson MJ; Caldas Y; Cho A; Tovar-Salazar A; Canniff J; Schmader KE; Popmihajlov Z; Levin MJ
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine.
    Perciani CT; Jaoko W; Walmsley S; Farah B; Mahmud SM; Ostrowski M; Anzala O; Team KI; MacDonald KS
    BMJ Open; 2017 Sep; 7(9):e017391. PubMed ID: 28939581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of immunity to varicella-zoster virus after vaccination of healthcare workers.
    Saiman L; LaRussa P; Steinberg SP; Zhou J; Baron K; Whittier S; Della-Latta P; Gershon AA
    Infect Control Hosp Epidemiol; 2001 May; 22(5):279-83. PubMed ID: 11428437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccines for preventing herpes zoster in older adults.
    Gagliardi AM; Andriolo BN; Torloni MR; Soares BG
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD008858. PubMed ID: 26937872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying optimal vaccination scenarios to reduce varicella zoster virus transmission and reactivation.
    Bakker KM; Eisenberg MC; Woods RJ; Martinez ME
    BMC Med; 2022 Oct; 20(1):387. PubMed ID: 36209074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disseminated varicella infection caused by varicella vaccine strain in a child with low invariant natural killer T cells and diminished CD1d expression.
    Banovic T; Yanilla M; Simmons R; Robertson I; Schroder WA; Raffelt NC; Wilson YA; Hill GR; Hogan P; Nourse CB
    J Infect Dis; 2011 Dec; 204(12):1893-901. PubMed ID: 22043019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral strain identification in varicella vaccinees with disseminated rashes.
    LaRussa P; Steinberg SP; Shapiro E; Vazquez M; Gershon AA
    Pediatr Infect Dis J; 2000 Nov; 19(11):1037-9. PubMed ID: 11099082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.